Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Influenza, Human 15Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 5Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia 3Colorectal Neoplasms 3Neoplasms, Plasma Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Central Nervous System Neoplasms 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Skin Neoplasms 1Sezary Syndrome 1Serology Analysis 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1

Interventions

venetoclax 1fludarabine 1Influenza Vaccines 1Decitabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Older Patients × Influenza Vaccines × Clear all
NCT07052422 2025-07-04

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting
160 enrolled
Other neoplasm

Older Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡